Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2001 | 07-2001 | 04-2001 | 01-2001 | 10-2000 | |
| Sales | 752 | 516 | 245 | 178 | 281 |
| Cost of Goods | 318 | 212 | 94 | 74 | 120 |
| Gross Profit | 434 | 304 | 151 | 104 | 180 |
| Operating Expenses | 1,472 | 1,472 | 1,035 | 1,316 | 1,810 |
| Operating Income | -720 | -956 | -790 | -1,138 | -1,529 |
| Other Income | 13 | 10 | 2 | 8 | 109 |
| Pre-tax Income | -707 | -946 | -788 | -1,130 | -1,420 |
| Net Income Continuous | -707 | -946 | -788 | -1,130 | -1,409 |
| Net Income | $-707 | $-946 | $-788 | $-1,130 | $-1,409 |
| EPS Basic Total Ops | -0.50 | -0.25 | -0.25 | -0.50 | -0.50 |
| EPS Basic Continuous Ops | -0.26 | -0.36 | -0.31 | -0.45 | -0.50 |
| EPS Diluted Total Ops | -0.50 | -0.25 | -0.25 | -0.50 | -0.50 |
| EPS Diluted Continuous Ops | -0.26 | -0.36 | -0.31 | -0.45 | -0.50 |
| EBITDA(a) | $-710 | $-910 | $-740 | $-1,077 | $-1,469 |